Literature DB >> 19152188

Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance.

Xiangru Wu1, Vida Petrovic, Ian P Torode, Chung Wo Chow.   

Abstract

AIMS: To review the clinicopathological features and highlight the problems in the diagnosis and management of low grade fibromyxoid sarcomas (LGFMS).
METHODS: Three cases of LGFMS were studied with histology and immunohistochemistry, and cytogenetics in one. The features and problems were compared with those in the literature.
RESULTS: Two LGFMS had typical fibrotic and myxoid patterns showing abrupt transition from one to the other. Cellularity was low to moderate. Nuclei were medium sized and regular. In one of these the correct diagnosis was not made in the original needle biopsy resulting in inappropriate management. In the third tumour only myxoid areas were seen and the diagnosis was supported by cytogenetics showing a complex previously unreported translocation, t(7;18;16). One tumour recurred, one metastasised, and one has possible metastasis on imaging of the lungs.
CONCLUSION: LGFMS is a tumour with low grade histological features but a high risk of local recurrence and a significant risk of metastasis which can be very late. There should be a high index of suspicion for this rare tumour and a low threshold for sending tissue for cytogenetics and/or molecular genetics. Special precautions should be exercised in the interpretation of small biopsies of a spindle cell lesion with bland cytological features in children. If the diagnosis is unclear there must be a detailed follow up plan with a person responsible for monitoring the plan.

Entities:  

Mesh:

Year:  2009        PMID: 19152188     DOI: 10.1080/00313020802579276

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  12 in total

1.  Primary paravertebral low-grade fibromyxoid sarcoma.

Authors:  Woo Jin Lee; Chong Oon Park; Seung Hwan Yoon; Young Chae Chu
Journal:  J Korean Neurosurg Soc       Date:  2010-11-30

2.  A wolf in sheep's clothing: a benign perineurioma-like lesion that is not what it seems.

Authors:  Po Yin Tang; Sathiyamoorthy Selvarajan
Journal:  Singapore Med J       Date:  2018-11       Impact factor: 1.858

3.  Low grade fibromyxoid sarcoma: a case report and review of the literature.

Authors:  Christina Arnaoutoglou; Marios G Lykissas; Ioannis D Gelalis; Anna Batistatou; Anna Goussia; Michalis Doukas; Theodoros A Xenakis
Journal:  J Orthop Surg Res       Date:  2010-07-29       Impact factor: 2.359

4.  Low-grade fibromyxoid sarcoma of the hand: a case report.

Authors:  Guy Rubin; Micha Rinott; Alejandro Wolovelsky; Irit Elmalach; Nimrod Rozen
Journal:  Hand (N Y)       Date:  2010-06-16

Review 5.  Desmoid tumors: clinical features and treatment options for advanced disease.

Authors:  Bernd Kasper; Philipp Ströbel; Peter Hohenberger
Journal:  Oncologist       Date:  2011-04-08

6.  Head and Neck Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 15 Cases.

Authors:  Sandra Gjorgova Gjeorgjievski; Karen Fritchie; Judith Jebastin Thangaiah; Andrew L Folpe; Nasir Ud Din
Journal:  Head Neck Pathol       Date:  2021-09-24

7.  Low grade fibromyxoid sarcoma (Evans tumour) of the arm.

Authors:  Shalaka Indap; Manjiri Dasgupta; Nilay Chakrabarti; Abhishek Agarwal
Journal:  Indian J Plast Surg       Date:  2014-05

8.  A low grade fibromyxoid sarcoma originating from the masseter muscle: a case report.

Authors:  Eun Jung Lee; Hye Jin Hwang; Hyung Kwon Byeon; Heae Surng Park; Hong-Shik Choi
Journal:  J Med Case Rep       Date:  2015-08-21

9.  Fibromyxoid sarcoma of the leg.

Authors:  Uwe Wollina; Juliane Runge; Jaqueline Schönlebe
Journal:  Indian Dermatol Online J       Date:  2010-07

10.  Low-grade fibromyxoid sarcoma around the knee involving the proximal end of the tibia and patella: A rare case report.

Authors:  Jeetendra Bajpai; Saurav Shukla; Moazzam Jah; Alok Kumar Singh; Mohit Goel; Amit Mourya; Nikhil Sachdeva
Journal:  Oncol Lett       Date:  2014-02-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.